Scopia Capital Management 13F holdings, Q4 2011
Holdings as of December 31, 2011 · filings on SEC EDGAR · latest filing →
Scopia Capital Management disclosed 13 US equity positions worth $597.1m in its Q4 2011 13F filing. The largest position was S9Q at 30.2% of the reported book, followed by INTC and XEROX CORP. Against the Q3 2011 filing, it opened 4 new positions, added to 5 and reduced 4 among the top 13 holdings.
What did Scopia Capital Management own in Q4 2011? Top 13 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2011 |
|---|---|---|---|---|---|---|---|
| 1 | S9Q SPIRIT AEROSYSTEMS HLDGS INC | 30.2% | $180.3m | 8,675,750 | -5% | reduced | |
| 2 | INTC INTEL CORP | Technology | 21.1% | $125.9m | 5,190,000 | – | new |
| 3 | XEROX CORP | 11.5% | $68.8m | 8,642,260 | 4% | added | |
| 4 | PHH CORP | 10.0% | $59.6m | 5,565,817 | 1% | added | |
| 5 | PLAINS EXPL& PRODTN CO | 8.3% | $49.5m | 1,347,224 | 18% | added | |
| 6 | TRIP TRIPADVISOR INC | Consumer Cyclical | 7.6% | $45.3m | 1,797,901 | – | new |
| 7 | OMNICARE INC | 6.2% | $37.0m | 1,072,705 | – | new | |
| 8 | VIVUS INC | 1.6% | $9.8m | 1,000,100 | – | new | |
| 9 | ALLOS THERAPEUTICS INC | 1.4% | $8.4m | 5,907,483 | 81% | added | |
| 10 | LUFKIN INDS INC | 1.1% | $6.5m | 96,196 | -34% | reduced | |
| 11 | SEATTLE GENETICS INC | 0.6% | $3.4m | 202,114 | -34% | reduced | |
| 12 | QLT INC | 0.3% | $1.7m | 237,835 | 1866% | added | |
| 13 | AMERICAN SUPERCONDUCTOR CORP | 0.2% | $1.2m | 312,920 | -45% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.